Market Overview

Vetr Urges Buy On Juno After Earnings


The Vetr crowd upgraded its rating for Juno Therapeutics Inc (NASDAQ: JUNO) on Monday from 4 stars (Buy), issued five days ago, to 5 stars (Strong Buy). Crowd sentiment at the time of the upgrade was mostly positive, with 87 percent of Vetr user rating bullish.

Share price in the biotech company experienced a fairly substantial correction following Friday's earnings report that saw revenue exceed expectations to the tune of nearly $6 million, while EPS remained in the red, meeting estimates of $(0.71).

The underwhelming report resulted in a more than 8.5 percent drop for the stock on Friday. That continued into the next week and Juno finished today's trading day at $22.16, about $3.50 below its pre-earnings close.

Learn how crowdsourced ratings could help you time the market.

Currently, the Vetr crowd's average target price is up at $27.94, which is still well below the average analyst target price of $34.50. Less than 2 percent of Vetr users are holding JUNO in their watch lists.

Latest Ratings for JUNO

Jan 2018Standpoint ResearchDowngradesBuyHold
Jan 2018BarclaysDowngradesOverweightEqual-Weight
Jan 2018Maxim GroupDowngradesBuyHold

View More Analyst Ratings for JUNO
View the Latest Analyst Ratings


Related Articles (JUNO)

View Comments and Join the Discussion!

Posted-In: VetrBiotech Upgrades Price Target Crowdsourcing Analyst Ratings

Latest Ratings

SOLOAegis CapitalAssumes4.0
TSLAJP MorganMaintains295.0
PFSICredit SuisseMaintains46.0
PMTCredit SuisseMaintains22.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at